| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Liquiritin | Cardiac Hypertrophy | 1 | PM | 35592411 | 📋 | Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway |
| Liquiritin | Cardiac Hypertrophy | 2 | PM | 35341136 | 📋 | Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway |
| Liquiritin | Cardiotoxicity | 1 | PM | 37160483 | 📋 | Liquiritin reduces ferroptosis in doxorubicin-induced cardiotoxicity through targeting SLC7A11/GPX4 pathway |
| Liquiritin | Cerebral Ischemia-Reperfusion | 1 | PM | 34295249 | 📋 | The Protective Effect of Liquiritin in Hypoxia/Reoxygenation-Induced Disruption on Blood Brain Barrier |
| Liquiritin | Cerebral Ischemia-Reperfusion | 2 | PM | 21128146 | 📋 | Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties |
| Liquiritin | Coronary Artery Disease | 1 | PM | 35038972 | 📋 | Protective effect of liquiritin on coronary heart disease through regulating the proliferation of human vascular smooth muscle cells via upregulation of sirtuin1 |
| Liquiritin | Heart Failure | 1 | PM | 35929638 | 📋 | Liquiritin inhibits H 2 O 2 -induced oxidative stress injury in H9c2 cells via the AMPK/SIRT1/NF-κB signaling pathway |
| Liquiritin | Myocardial Fibrosis | 2 | PM | 36483459 | 📋 | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway |
| Liquiritin | Myocardial Fibrosis | 1 | PM | 27810791 | 📋 | The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-κB and MAPK signaling pathway |
| Liquiritin | Myocardial Hypoxia | 1 | PM | 34413986 | 📋 | Liquiritin from Radix Glycyrrhizae Protects Cardiac Mitochondria from Hypoxia/Reoxygenation Damage |
| Liquiritin | Myocardial Infarction | 1 | PM | 36483459 | 📋 | Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway |
| Liquiritin | Myocardial Injury | 2 | PM | 35929638 | 📋 | Liquiritin inhibits H 2 O 2 -induced oxidative stress injury in H9c2 cells via the AMPK/SIRT1/NF-κB signaling pathway |
| Liquiritin | Myocardial Ischemia-Reperfusion | 1 | PM | 38361515 | 📋 | Mechanistic investigation of the ameliorative effect of liquiritin on hypoxia/reoxygenation‑induced cardiomyocyte injury based on network pharmacology and in vitro validation |
| Liquiritin | Stroke | 1 | PM | 34295249 | 📋 | The Protective Effect of Liquiritin in Hypoxia/Reoxygenation-Induced Disruption on Blood Brain Barrier |
